Загрузка...
Mechanisms, monitoring, and management of tyrosine kinase inhibitors–associated cardiovascular toxicities
The tyrosine kinase inhibitor (TKI) drug class is a prominently used option in the treatment of various cancers. Safety evaluation of these drugs has shown evidence of cardiotoxicity of varying frequency and severity between agents; concern has led to updated labeling, warning prescribers of such. T...
Сохранить в:
| Опубликовано в: : | Onco Targets Ther |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6163027/ https://ncbi.nlm.nih.gov/pubmed/30288058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S170138 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|